Progressive multifocal leukoencephalopathy

CONTINUUM Lifelong Learning in Neurology

Volumn 18, Issue 6, 2012, Pages 1374-1391

  Aksamit, Allen J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; CAMPTOTHECIN; CHLORPROMAZINE; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; EFALIZUMAB; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MEFLOQUINE; METHOTREXATE; METHYLPREDNISOLONE; MIRTAZAPINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NATALIZUMAB; PREDNISONE; RISPERIDONE; RITUXIMAB; TOPOTECAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CEREBROSPINAL FLUID ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; DEMYELINATION; DISEASE PREDISPOSITION; DRUG MEGADOSE; GRAFT RECIPIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; JC VIRUS; LYMPHOMA; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; ORGAN TRANSPLANTATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSORIASIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE;

EID: 84871949190     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000423852.70641.de     Document Type: Review

References (58)

1. Astrom KE, Mancall EL, Richardson EP Jr. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958;81(1):93-111
2. Richardson EP Jr. Progressive multifocal leukoencephalopathy. N Engl J Med 1961;265:815-823
3. Zurhein G, Chou SM. Particles resembling papova viruses in human cerebral demyelinating disease. Science 1965;148(3676):1477-1479
4. Padgett BL, Walker DL, ZuRhein GM, et al. Cultivation of papovalike virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971;1(7712):1257-1260
5. Walker D, Frisque R. The biology and molecular biology of JC virus. In: Salzman NP, ed. The papovaviridae. New York: Plenum Press, 1986
6. Weiner LP, Herndon RM, Narayan O, et al. Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 1972;286(8):385-390
7. Castaigne P, Rondot P, Escourolle R, et al. [Progressive multifocal leukoencephalopathy and multiple gliomas.] Rev Neurol (Paris) 1974;130(9-10):379-392
8. Del Valle L, Azizi SA, Krynska B, et al. Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastoma multiforme. Ann Neurol 2000;48(6):932-936
9. Major EO. From telomeres to T-antigens: Many roadsImultiple pathwaysInovel associations in the search for the origins of human gliomas. Ann Neurol 2000;48(6):823-825
10. Major EO, Amemiya K, Tornatore CS, et al. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992;5(1):49-73
11. Berenguer J, Miralles P, Arrizabalaga J, et al. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active ntiretroviral therapy. Clin Infect Dis 2003;36(8):1047-1052
12. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998;4(1):59-68
13. Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984;2(2):299-313
14. Frisque RJ, Bream GL, Cannella MT. Human polyomavirus JC virus genome. J Virol 1984;51(2):458-469
15. Aksamit AJ, Mourrain P, Sever JL, Major EO. Progressive multifocal leukoencephalopathy: Investigation of three cases using in situ hybridization with JC virus biotinylated DNA probe. Ann Neurol 1985;18(4):490-496
16. Aksamit AJ, Sever JL, Major EO. Progressive multifocal leukoencephalopathy: JC virus detection by in situ hybridization compared with immunohistochemistry. Neurology 1986;36(4):499-504
17. Houff SA, Major EO, Katz DA, et al. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive ultifocal leukoencephalopathy. N Engl J Med 1988;318(5):301-305
18. Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? Ann Neurol 2006;60(2):162-173
19. McGuire D, Barhite S, Hollander H, Miles M. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: Predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 1995;37(3):395-399
20. Telenti A, Marshall WF, Aksamit AJ, et al. Detection of JC virus by polymerase chain reaction in cerebrospinal fluid from two patients with progressive multifocal leukoencephalopathy. Eur J Clin Microbiol Infect Dis 1992;11(3):253-254
21. Ryschkewitsch CF, Jensen PN, Monaco MC, Major EO. JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Ann Neurol 2010;68(3):384-391
22. Hall CD, Dafni U, Simpson D, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 1998;338(19):1345-1351
23. Clifford DB, De Luca A, Simpson DM, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: Lessons from 28 cases. Lancet Neurol 2010;9(4):438-446
24. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005;353(4):369-374
25. Langer-Gould A, Atlas SW, Green AJ, et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005;353(4):375-381
26. Berger JR, Houff S. Opportunistic infections and other risks with newer multiple sclerosis therapies. Ann Neurol 2009;65(4):367-377
27. Clifford DB, Ances B, Costello C, et al. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 2011;68(9):1156-1164
28. Berger Jr. Steroids for PML-IRIS: A double-edged sword? Neurology 2009;72(17):1454-1455
29. Tan K, Roda R, Ostrow L, et al. PML-IRIS in patients with HIV infection: Clinical manifestations and treatment with steroids. Neurology 2009;72(17):1458-1464
30. Bozic C, Richman S, Plavina T, et al. Anti-John Cunningham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1. Ann Neurol 2011;70(5):742-750
31. Aksamit AJ Jr. Progressive multifocal leukoencephalopathy: A review of the pathology and pathogenesis. Microsc Res Tech 1995;32(4):302-311
32. Major EO, Amemiya K, Elder G, Houff SA. Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. J Neurosci Res 1990;27(4):461-471
33. Van Assche G, Van Ranst M, Sciot R, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005;353(4):362-368
34. Razonable RR, Aksamit AJ, Wright AJ, Wilson JW. Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc 2001;76(11):1171-1175
35. Calabrese LH, Molloy ES. Progressive multifocal leucoencephalopathy in the rheumatic diseases: Assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis 2008;67(suppl 3):iii64Yiii65
36. Mateen FJ, Muralidharan R, Carone M, et al. Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol 2011;70(2): 305-322
37. Rudick RA, Stuart WH, Calabresi PA, et al. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 2006;354(9):911-923
38. Rahmlow M, Shuster EA, Dominik J, et al. Leflunomide-associated progressive multifocal leukoencephalopathy. Arch Neurol 2008;65(11):1538-1539
39. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: A report of 57 cases from the Research on Adverse Drug Events and Reports Project. Blood 2009;113(20): 4834-4840
40. Korman BD, Tyler KL, Korman NJ. Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: A cautionary tale for dermatologists. Arch Dermatol 2009;145(8):937-942
41. Whiteman ML, Post MJ, Berger JR, et al. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: Neuroimaging with clinical and pathologic correlation. Radiology 1993;187(1):233-240
42. Bossolasco S, Calori G, Moretti F, et al. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 2005;40(5):738-744
43. Weber T, Turner RW, Frye S, et al. Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 1994;8(1):49-57
44. Aksamit AJ. Cerebrospinal fluid in the diagnosis of central nervous system infections. In: Roos KL, ed. Central nervous system infectious diseases and therapy. New York, NY: Marcel Dekker, Inc, 1997:731-745
45. Aksamit AJ Jr. Nonradioactive in situ hybridization in progressive multifocal leukoencephalopathy. Mayo Clin Proc 1993;68(9):899-910
46. Du Pasquier RA, Corey S, Margolin DH, et al. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology 2003;61(6):775-782
47. Clifford DB, Yiannoutsos C, Glicksman M, et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999;52(3):623-625
48. Aksamit AJ. Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 2001;7(4):386-390
49. Viallard JF, Lazaro E, Ellie E, et al. Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive olyarthritis. Infection 2007;35(1): 33-36
50. De Luca A, Ammassari A, Pezzotti P, et al. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: A multicohort analysis. AIDS 2008;22(14):1759-1767
51. Marra CM, Rajicic N, Barker DE, et al. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in aids. AIDS 2002;16(13):1791-1797
52. Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004;306(5700):1380-1383
53. Owczarczyk K, Hilker R, Brunn A, et al. Progressive multifocal leucoencephalopathy in a patient with sarcoidosisVsuccessful treatment with cidofovir and mirtazapine. Rheumatology (Oxford) 2007;46(5):888-890
54. Vulliemoz S, Lurati-Ruiz F, Borruat FX, et al. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry 2006;77(9):1079-1082
55. Kast RE, Focosi D, Petrini M, Altschuler EL. Treatment schedules for 5-HT2a blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone. one Marrow Transplant 2007;39(12):811-812
56. Clifford D, Nath A, Cinque P, et al. Mefloquine treatment in patients with progressive multifocal leukoencephalopathy. Neurology 2011;76:A28
57. Nath A, Venkataramana A, Reich DS, et al. Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon. Neurology 2006;66(1):149-150
58. Royal W 3rd, Dupont B, McGuire D, et al. Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol 2003;9(3):411-419.